Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China

Figure 6 Signature of gene differences based on different tumor size changes. Response standard and partial response were clustered as a group encountering tumor size reduction in response to treatment, which appears green. Tumor size change, progression standard and progressive disease were clustered into a group that did not respond with tumor size reduction, which appears red. The blue block highlights the existence of specific genes, and the left brown block represents the gene that mainly appears in either the tumor reduction or without reduction groups. SS: Response standard; ST: Tumor size change; SP: Progression standard; PD: Progressive disease; PR: Partial response.